U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

WHO Guidelines on Hepatitis B and C Testing. Geneva: World Health Organization; 2017 Feb.

Cover of WHO Guidelines on Hepatitis B and C Testing

WHO Guidelines on Hepatitis B and C Testing.

Show details

ANNEX 1The Global Hepatitis Health Sector Strategy – Global Targets

TARGET AREABASELINE 20152020 TARGETS2030 TARGETS
Impact targets
Incidence: New cases of chronic viral hepatitis B and C infectionsBetween 6 and 10 million infections are reduced to 0.9 million infections by 2030 (95% decline in hepatitis B virus infections, 80% decline in hepatitis C virus infections)30% reduction (equivalent to 1% prevalence of HBsAg1 among children)90% reduction (equivalent to 0.1% prevalence of HBsAg among children)
Mortality: Viral hepatitis B and C deaths1.4 million deaths reduced to less than 500 000 by 2030 (65% for both viral hepatitis B and C)10% reduction65% reduction
Service coverage targets
Hepatitis B virus vaccination: childhood vaccine coverage (third dose coverage)82%2 in infants90%90%
Prevention of hepatitis B virus mother-to-child transmission: hepatitis B virus birth-dose vaccination coverage or other approach to prevent mother-to-child transmission38%50%90%
Blood safety39 countries do not routinely test all blood donations for transfusiontransmissible infections 89% of donations screened in a qualityassured manner3All countries have haemovigilance systems in place to identify and quantify viral hepatitis transfusion transmission ratesReduce rates of transmission by 99% compared with 2020.
Safe injections: percentage of injections administered with safetyengineered devices in and out of health facilities5%50%90%
Harm reduction: number of sterile needles and syringes provided per person who injects drugs per year20200300
Viral hepatitis B and C diagnosis<5% of chronic hepatitis infections diagnosed50%90%
Viral hepatitis B and C treatment<1% receiving treatment5 million people receiving hepatitis B virus treatment 3 million people received hepatitis C virus treatment80% of eligible persons with chronic hepatitis B virus infection treated 80% of eligible persons with chronic hepatitis C virus infection treated
1

The abbreviation “HBsAg” refers to hepatitis B virus surface antigen.

2

WHO/UNICEF coverage estimates 2013 revision, July 2014, see: http://apps​.who.int/immunization​_monitoring​/globalsummary/timeseries​/tswucoveragebcg.html (accessed 1 November 2015).

3

Global Database on Blood Safety, Summary Report 2011, see: http://www​.who.int/bloodsafety​/global_database​/GDBS_Summary_Report_2011.pdf?ua=1 (accessed 1 November 2015).

Copyright © World Health Organization 2017.

Sales, rights and licensing. To purchase WHO publications, see http://apps.who.int/bookorders. To submit requests for commercial use and queries on rights and licensing, see http://www.who.int/about/licensing.

Third-party materials. If you wish to reuse material from this work that is attributed to a third party, such as tables, figures or images, it is your responsibility to determine whether permission is needed for that reuse and to obtain permission from the copyright holder. The risk of claims resulting from infringement of any third-party-owned component in the work rests solely with the user.

Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo).

Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “The translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”.

Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization.

Bookshelf ID: NBK442270

Views

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...